Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway

BACKGROUND: Immune checkpoint blockade (ICB) has revolutionized cancer treatment. However, ICB alone has demonstrated only benefit in a small subset of patients with breast cancer. Recent studies have shown that agents targeting DNA damage response improve the efficacy of ICB and promote cytosolic D...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Dai, Hui, Huo, Lei, Burks, Jared K, McGrail, Daniel J, Lin, Shiaw-Yih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619126/
https://www.ncbi.nlm.nih.gov/pubmed/37907220
http://dx.doi.org/10.1136/jitc-2023-007560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619126/
https://www.ncbi.nlm.nih.gov/pubmed/37907220
http://dx.doi.org/10.1136/jitc-2023-007560

Ejemplares similares